Irinotecan hydrochloride contains not less than 98.0 percent and not more than 102.0 percent of C33H38N4O6HCl?3H2O calculated on the dried basis.

共有 1 個藥物證書使用此成份

申請商
台灣神隆股份有限公司 
適應症
抗癌藥(Antineoplastic)。
含量
0.000000
發證日期
2006-09-07